Company / Capital Expenditures
Bruker Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$90.8M
FY2025
5-year range
$90.8M / $129.2M
FY2021-FY2025
Trend
-21.2%
vs FY2024
Sector context
#61 of 145
Health Care
What the data says
At $91M, Bruker's capital expenditures ranks #61 of 145 in the Health Care sector. Capital Expenditures has fluctuated over the past 10 years, ranging from $12M in FY2020 to $129M in FY2022.
Based on SEC 10-K filings.
$91M in FY2025 with a 5-year CAGR of +49.2%.
Declined from $107M to $91M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -11.1%
- 5-Year CAGR
- +49.2%
- 10-Year CAGR
- -
Sector benchmark
#61 of 145 in Health CareTop 42% of 145This company $90.8M Sector average $268.6M
▼
-66.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +49.2%, indicating consistent growth.
- In FY2025, capital expenditures decreased 21.2% year-over-year.
- Ranks #61 out of 145 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2022.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $90.8M | -21.2% |
| FY2024 | $115.3M | +7.9% |
| FY2023 | $106.9M | -17.3% |
| FY2022 | $129.2M | +40.4% |
| FY2021 | $92.0M | +648.0% |
| FY2020 | $12.3M | -83.2% |
| FY2019 | $73.0M | +48.4% |
| FY2018 | $49.2M | +12.6% |
| FY2017 | $43.7M | +17.8% |
| FY2016 | $37.1M | +8.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026